| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |